Cargando…
Pharmacokinetics of metformin in patients with gastrointestinal intolerance
AIMS: To assess potential causes of metformin intolerance, including altered metformin uptake from the intestine, increased anaerobic glucose utilization and subsequent lactate production, altered serotonin uptake, and altered bile acid pool. METHODS: For this pharmacokinetic study, we recruited 10...
Autores principales: | McCreight, Laura J., Stage, Tore B., Connelly, Paul, Lonergan, Mike, Nielsen, Flemming, Prehn, Cornelia, Adamski, Jerzy, Brøsen, Kim, Pearson, Ewan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033038/ https://www.ncbi.nlm.nih.gov/pubmed/29457876 http://dx.doi.org/10.1111/dom.13264 |
Ejemplares similares
-
Metformin and the gastrointestinal tract
por: McCreight, Laura J., et al.
Publicado: (2016) -
Oral and intravenous pharmacokinetics of metformin with and without oral codeine intake in healthy subjects: A cross‐over study
por: Kuhlmann, Ida, et al.
Publicado: (2021) -
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
por: McCreight, Laura J., et al.
Publicado: (2019) -
Cytochrome P450 2D6 genotype–phenotype characterization through population pharmacokinetic modeling of tedatioxetine
por: Frederiksen, Trine, et al.
Publicado: (2021) -
Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine
por: Frederiksen, Trine, et al.
Publicado: (2020)